loadpatents
Patent applications and USPTO patent grants for Her; Jeng-Horng.The latest application filed is for "antibodies for t-cell activation".
Patent | Date |
---|---|
Fusion protein comprising a ligand binding domain of VEGF and PDGF Grant 11,299,531 - Zen , et al. April 12, 2 | 2022-04-12 |
Antibodies For T-cell Activation App 20200407456 - YOU; Jhong-Jhe ;   et al. | 2020-12-31 |
Bifunctional Proteins Combining Checkpoint Blockade for Targeted Therapy App 20200299389 - Her; Jeng-Horng ;   et al. | 2020-09-24 |
Monospecific and Bispecific Proteins with Immune Checkpoint Regulation for Cancer Therapy App 20200270357 - You; Jhong-Jhe ;   et al. | 2020-08-27 |
Protein Inhibitors To Complement And Vegf Pathways And Methods Of Use Thereof App 20180312819 - HER; Jeng-Horng ;   et al. | 2018-11-01 |
Protein inhibitors to complement and VEGF pathways and methods of use thereof Grant 9,988,611 - Her , et al. June 5, 2 | 2018-06-05 |
Fusion Protein Comprising A Ligand Binding Domain Of Vegf And Pdgf App 20170369552 - ZEN; Kevin ;   et al. | 2017-12-28 |
Protein Inhibitors To Complement And Vegf Pathways And Methods Of Use Thereof App 20150079084 - Her; Jeng-Horng ;   et al. | 2015-03-19 |
GPCR Expressing Cell Lines and Antibodies App 20120219968 - Mancebo; Helena S. ;   et al. | 2012-08-30 |
GPCR expression vector Grant 8,178,346 - Mancebo , et al. May 15, 2 | 2012-05-15 |
Detection of molecular interactions by .beta.-lactamase reporter fragment complementation Grant 8,148,110 - Blau , et al. April 3, 2 | 2012-04-03 |
Antibody specificity transfer using minimal essential binding determinants Grant 7,981,843 - Flynn , et al. July 19, 2 | 2011-07-19 |
GPCR Expressing Cell Lines and Antibodies App 20100330591 - Mancebo; Helena S. ;   et al. | 2010-12-30 |
GPCR-expressing cell lines Grant 7,781,209 - Mancebo , et al. August 24, 2 | 2010-08-24 |
Circularly permutated, interaction-activated proteins Grant 7,544,477 - Balint , et al. June 9, 2 | 2009-06-09 |
Methods for affinity maturation Grant 7,432,063 - Balint , et al. October 7, 2 | 2008-10-07 |
Reactivation-based molecular interaction sensors Grant 7,335,478 - Balint , et al. February 26, 2 | 2008-02-26 |
GPCR expressing cell lines and antibodies App 20070196867 - Mancebo; Helena S. ;   et al. | 2007-08-23 |
Antibody specificity transfer using minimal essential binding determinants App 20050255552 - Flynn, Peter ;   et al. | 2005-11-17 |
Antibody affinity engineering by serial epitope-guided complementarity replacement App 20050008625 - Balint, Robert F. ;   et al. | 2005-01-13 |
Methods for affinity maturation App 20040132066 - Balint, Robert F. ;   et al. | 2004-07-08 |
Breakpoint fusion fragment complementation system App 20040038317 - Balint, Robert F. ;   et al. | 2004-02-26 |
Reactivation-based molecular interaction sensors App 20030198971 - Balint, Robert F. ;   et al. | 2003-10-23 |
Detection of molecular interactions by beta-lactamase reporter fragment complementation App 20030175836 - Blau, Helen M. ;   et al. | 2003-09-18 |
Interaction-activated, circularly permutated proteins App 20030165825 - Balint, Robert F. ;   et al. | 2003-09-04 |
Affinity maturation by competitive selection App 20020155502 - Balint, Robert F. ;   et al. | 2002-10-24 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.